Copenhagen, Denmark and Buffalo Grove, Illinois, USA, 27 June, 2022 – Xellia Pharmaceuticals USA, LLC, today announced that it is a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement and technology company that unites an alliance of more than 4,400 U.S. hospitals and health systems and approximately 225,000 other providers.
One of 10 suppliers to receive the award this year, Xellia Pharmaceuticals USA, LLC, was recognized for its support of Premier members through exceptional customer service and engagement, ability to drive value through clinical excellence and commitment to sustainable costs.
“We are honored to be receiving this award, as it is a testimony of not only our ambition as an organization to support our customers through a robust supply chain and with customer service excellence, but at the end of the day demonstrates a testimony to our patient focus. Xellia is a proud manufacturer of generic critical anti-infective treatments and specialty injectables, and as we continue on our journey it is through the important collaborations with customers and group purchasing partners, we can ensure reaching patients in need, with critical-care medicines,” said Peter Baker, Chief Commercial Officer, North America.
Horizon Award winner/winners have tenure of fewer than three years as a Premier contracted supplier.
“Xellia Pharmaceuticals USA, LLC, supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies,” said David A. Hargraves, Senior Vice President, Supply Chain, Premier. “We’re honored to recognize them as a Horizon Award recipient.”
